Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

about

Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment.Endoplasmic Reticulum Protein Quality Control Failure in Myelin Disorders.Is Parkinson's disease a lysosomal disorder?

P2860

Q38751654-E34F94BC-5D40-4845-8FF8-DE3C090AE1C8 Q39094240-E7D01247-9CF5-4B42-9B9C-8FDAEF2C5BC2 Q58479932-C012146A-503E-44A6-810A-836F8B3D10CA

P2860

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Item

http://www.wikidata.org/entity/Q38957246

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

@en

type

Item

label

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

@en

prefLabel

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

@en

P1476

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

@en

P2093

Avtar K Singh

http://www.w3.org/2001/XMLSchema#string

Inderjit Singh

http://www.w3.org/2001/XMLSchema#string

Je-Seong Won

http://www.w3.org/2001/XMLSchema#string

P2860

Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease

Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones

FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology

Molecular heterogeneity of late-onset forms of globoid-cell leukodystrophy

Identification of a molecular target of psychosine and its role in globoid cell formation.

Anti-inflammatory therapy by ibudilast, a phosphodiesterase inhibitor, in demyelination of twitcher, a genetic demyelination model

Innate immunity in the central nervous system

Insights into Krabbe disease from structures of galactocerebrosidase

Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Metabolism of highly unsaturated n-3 and n-6 fatty acids

P304

990-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23873

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27638584

http://www.w3.org/2001/XMLSchema#string

P932

5812347

http://www.w3.org/2001/XMLSchema#string

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

about

P2860

P2860

Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932